We are a new biopharmaceutical company spin-out from the University of Cambridge with a first-in-class technology platform. We offer exciting science and business career opportunities for enthusiastic candidates who thrive on innovation, enjoy teamwork and want to make a difference to the lives of patients with life-changing diseases, such as cancer.
We are working in the exciting new field of targeted protein degradation, with a focus on discovery and development of novel biopharmaceuticals that selectively target cancer-causing proteins that have proved intractable using other drug classes. Our proprietary Polyproxin™ technology uses state-of-the-art bioinformatic and protein engineering techniques to discover drug candidates for preclinical and clinical studies.
Our research laboratories are at the Babraham Research Campus, Cambridge. We recently completed our Seed Financing with a syndicate of blue-chip healthcare investors and are now recruiting our formative team of scientists.
We currently have vacancies for: